China Resources Pharmaceutical Group Limited (HKG:3320)
Hong Kong
· Delayed Price · Currency is HKD 5.24
+0.03 (0.58%)
Apr 29, 2026, 4:08 PM HKT
HKG:3320 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 32,732 | 27,957 | 35,810 | 32,229 | 39,705 | 22,303 | Upgrade
|
| Market Cap Growth | 0% | -21.93% | 11.11% | -18.83% | 78.03% | -10.80% | Upgrade
|
| Enterprise Value | 169,173 | 152,391 | 134,493 | 125,637 | 127,867 | 104,251 | Upgrade
|
| Last Close Price | 5.21 | 4.45 | 5.55 | 4.76 | 5.74 | 3.11 | Upgrade
|
| PE Ratio | 7.28 | 6.22 | 10.10 | 7.59 | 10.03 | 5.92 | Upgrade
|
| Forward PE | 6.61 | 6.57 | 7.10 | 6.11 | 8.75 | 5.81 | Upgrade
|
| PS Ratio | 0.11 | 0.09 | 0.13 | 0.12 | 0.16 | 0.09 | Upgrade
|
| PB Ratio | 0.25 | 0.21 | 0.34 | 0.32 | 0.44 | 0.24 | Upgrade
|
| P/TBV Ratio | 1.85 | 1.58 | 1.78 | 1.63 | 2.09 | 1.20 | Upgrade
|
| P/FCF Ratio | - | - | 2.26 | 2.25 | 4.11 | 2.14 | Upgrade
|
| P/OCF Ratio | - | - | 1.92 | 1.88 | 3.25 | 1.74 | Upgrade
|
| PEG Ratio | 0.59 | 0.62 | 0.62 | 0.62 | 0.62 | 0.62 | Upgrade
|
| EV/Sales Ratio | 0.56 | 0.51 | 0.49 | 0.47 | 0.52 | 0.44 | Upgrade
|
| EV/EBITDA Ratio | 9.77 | 8.95 | 8.64 | 8.40 | 9.68 | 8.73 | Upgrade
|
| EV/EBIT Ratio | 11.78 | 10.83 | 10.55 | 10.34 | 11.61 | 10.59 | Upgrade
|
| EV/FCF Ratio | - | - | 8.49 | 8.75 | 13.24 | 10.00 | Upgrade
|
| Debt / Equity Ratio | 0.62 | 0.62 | 0.70 | 0.67 | 0.70 | 0.72 | Upgrade
|
| Debt / EBITDA Ratio | 4.73 | 4.73 | 4.50 | 4.38 | 4.59 | 5.37 | Upgrade
|
| Debt / FCF Ratio | - | - | 4.63 | 4.77 | 6.61 | 6.52 | Upgrade
|
| Net Debt / Equity Ratio | 0.48 | 0.48 | 0.44 | 0.32 | 0.42 | 0.41 | Upgrade
|
| Net Debt / EBITDA Ratio | 3.70 | 3.70 | 2.96 | 2.21 | 2.88 | 3.22 | Upgrade
|
| Net Debt / FCF Ratio | - | - | 2.91 | 2.30 | 3.94 | 3.69 | Upgrade
|
| Asset Turnover | 0.99 | 0.99 | 1.02 | 1.06 | 1.00 | 1.03 | Upgrade
|
| Inventory Turnover | 5.60 | 5.60 | 6.30 | 7.07 | 6.99 | 7.42 | Upgrade
|
| Quick Ratio | 0.83 | 0.83 | 1.03 | 1.00 | 0.94 | 0.95 | Upgrade
|
| Current Ratio | 1.42 | 1.42 | 1.41 | 1.33 | 1.25 | 1.25 | Upgrade
|
| Return on Equity (ROE) | 8.96% | 8.96% | 8.80% | 8.96% | 8.09% | 7.60% | Upgrade
|
| Return on Assets (ROA) | 2.91% | 2.91% | 2.97% | 2.98% | 2.80% | 2.69% | Upgrade
|
| Return on Invested Capital (ROIC) | 5.95% | 6.56% | 6.97% | 7.32% | 6.96% | 6.12% | Upgrade
|
| Return on Capital Employed (ROCE) | 8.80% | 8.80% | 9.50% | 9.80% | 10.40% | 9.20% | Upgrade
|
| Earnings Yield | 13.74% | 16.10% | 9.96% | 13.18% | 9.97% | 16.90% | Upgrade
|
| FCF Yield | - | - | 44.25% | 44.53% | 24.32% | 46.76% | Upgrade
|
| Dividend Yield | 4.27% | 4.85% | 2.59% | 3.56% | 2.79% | 4.82% | Upgrade
|
| Payout Ratio | - | - | 44.44% | 22.83% | 23.23% | 20.00% | Upgrade
|
| Buyback Yield / Dilution | - | - | - | - | - | 0.01% | Upgrade
|
| Total Shareholder Return | 4.21% | 4.85% | 2.59% | 3.56% | 2.79% | 4.83% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.